The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells

Methods in Molecular Biology

Volumn 942, Issue , 2013, Pages 135-152

  Chang, Chanil ^a   Hong, Sun Woo ^a   Dua, Pooja ^a   Kim, Soyoun ^a   Lee, Dong Ki ^a  

^a NONE

Author keywords

AsiRNA; Off target silencing; RNAi; RNAi machinery saturation; SiRNA

Indexed keywords

MICRORNA; SMALL INTERFERING RNA;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FUNCTIONAL GENOMICS; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; RNA INTERFERENCE; RNA STRUCTURE;

EID: 84934439808     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-119-6_7     Document Type: Article

References (23)

1. Hannon GJ (2002) RNA interference. Nature 418:244-251
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
3. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20:6877-6888
4. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6:443-453
5. Lares MR, Rossi JJ, Ouellet DL (2010) RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol 28:570-579
6. Scherer L, Rossi JJ, Weinberg MS (2007) Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther 14:1057-1064
7. Jackson AL, Linsley PS (2004) Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20:521-524
8. Jackson AL et al (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637
9. Clark PR, Pober JS, Kluger MS (2008) Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: dissection of an off-target effect. Nucleic Acids Res 36:1081-1097
10. Yoo JW, Kim S, Lee DK (2007) Competition potency of siRNA is specified by the 5′-half sequence of the guide strand. Biochem Biophys Res Commun 367:78-83
11. Koller E et al (2006) Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res 34:4467-4476
12. Vickers TA, Lima WF, Nichols JG, Crooke ST (2007) Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells. Nucleic Acids Res 35:6598-6610
13. Grimm D et al (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537-541
14. Kleinman ME et al (2008) Sequence- and target- independent angiogenesis suppression by siRNA via TLR3. Nature 452:591-597
15. Amarzguioui M, Holen T, Babaie E, Prydz H (2003) Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31:589-595
16. Chiu YL, Rana TM (2003) siRNA function in RNAi: a chemical modification analysis. RNA 9:1034-1048
17. Chang CI et al (2009) Asymmetric shorterduplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol Ther 17:725-732
18. Soutschek J et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173-178
19. Barik S (2006) RNAi in moderation. Nat Biotechnol 24:796-797
20. Marques JT, Williams BR (2005) Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23:1399-1405
21. Choung S, Kim YJ, Kim S, Park HO, Choi YC (2006) Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 342:919-927
22. Jo SG, Hong SW, Yoo JW, Lee CH, Kim S, Lee DK (2011) Selection and optimization of asymmetric siRNA targeting the human c-MET gene. Mol Cells 32:543-548
23. van Dongen S, Abreu-Goodger C, Enright AJ (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5:1023-1025